Explore a comprehensive webinar on identifying patients at risk for hereditary cancer and the benefits of genetic testing. Learn about the differences between hereditary and sporadic cancer, germline and somatic mutations, and tumor suppressor genes. Discover tools and skills used to identify at-risk patients, including NCCN guidelines and professional organization recommendations. Delve into the history and types of genetic testing, panel testing, and the distinction between high and moderate risk cancer genes. Gain insights on universal cancer screening, family history findings, and considerations for testing children and adolescents. Address questions about life insurance implications, PanHematological cancer panels, and preimplantation genetic testing. Presented by Emily Dalton, MS, CGC, Director of Genetic Specialists at Ambry Genetics, this 56-minute session equips healthcare professionals with valuable knowledge to assess and counsel patients regarding hereditary cancer risk.